DE10105912A1 - Rekombinante Proteinase K - Google Patents

Rekombinante Proteinase K

Info

Publication number
DE10105912A1
DE10105912A1 DE10105912A DE10105912A DE10105912A1 DE 10105912 A1 DE10105912 A1 DE 10105912A1 DE 10105912 A DE10105912 A DE 10105912A DE 10105912 A DE10105912 A DE 10105912A DE 10105912 A1 DE10105912 A1 DE 10105912A1
Authority
DE
Germany
Prior art keywords
proteinase
recombinant
concentration
buffer
zymogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10105912A
Other languages
German (de)
English (en)
Inventor
Rainer Mueller
Helmut Schoen
Rainer Schmuck
Frank Geipel
Thomas Meier
Stephan Glaser
Bernhard Rexer
Johann-Peter Thalhofer
Bjoern Schott
Rainer Rudolph
Hauke Lilie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Priority to DE10105912A priority Critical patent/DE10105912A1/de
Priority to CZ20032165A priority patent/CZ20032165A3/cs
Priority to US10/467,532 priority patent/US20070099283A1/en
Priority to CA002435753A priority patent/CA2435753A1/en
Priority to PCT/EP2002/001322 priority patent/WO2002072634A2/de
Priority to EP02750504A priority patent/EP1360284B1/de
Priority to DE50212510T priority patent/DE50212510D1/de
Priority to JP2002571547A priority patent/JP2004525631A/ja
Priority to AT02750504T priority patent/ATE401393T1/de
Publication of DE10105912A1 publication Critical patent/DE10105912A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21064Peptidase K (3.4.21.64)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE10105912A 2001-02-09 2001-02-09 Rekombinante Proteinase K Withdrawn DE10105912A1 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE10105912A DE10105912A1 (de) 2001-02-09 2001-02-09 Rekombinante Proteinase K
CZ20032165A CZ20032165A3 (cs) 2001-02-09 2002-02-08 Rekombinantní proteináza K
US10/467,532 US20070099283A1 (en) 2001-02-09 2002-02-08 Recombinant proteinase k
CA002435753A CA2435753A1 (en) 2001-02-09 2002-02-08 Renaturation and activation of the proteinase k zmyogen produced in inclusion bodies
PCT/EP2002/001322 WO2002072634A2 (de) 2001-02-09 2002-02-08 Rekombinante proteinase k
EP02750504A EP1360284B1 (de) 2001-02-09 2002-02-08 Rekombinante proteinase k
DE50212510T DE50212510D1 (de) 2001-02-09 2002-02-08 Rekombinante proteinase k
JP2002571547A JP2004525631A (ja) 2001-02-09 2002-02-08 組換えプロテイナーゼk
AT02750504T ATE401393T1 (de) 2001-02-09 2002-02-08 Rekombinante proteinase k

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10105912A DE10105912A1 (de) 2001-02-09 2001-02-09 Rekombinante Proteinase K

Publications (1)

Publication Number Publication Date
DE10105912A1 true DE10105912A1 (de) 2002-08-14

Family

ID=7673417

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10105912A Withdrawn DE10105912A1 (de) 2001-02-09 2001-02-09 Rekombinante Proteinase K
DE50212510T Expired - Fee Related DE50212510D1 (de) 2001-02-09 2002-02-08 Rekombinante proteinase k

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE50212510T Expired - Fee Related DE50212510D1 (de) 2001-02-09 2002-02-08 Rekombinante proteinase k

Country Status (8)

Country Link
US (1) US20070099283A1 (https=)
EP (1) EP1360284B1 (https=)
JP (1) JP2004525631A (https=)
AT (1) ATE401393T1 (https=)
CA (1) CA2435753A1 (https=)
CZ (1) CZ20032165A3 (https=)
DE (2) DE10105912A1 (https=)
WO (1) WO2002072634A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153666B2 (en) 2003-07-17 2006-12-26 General Atomics Methods and compositions for determination of glycated proteins
ES2404059T3 (es) * 2006-07-25 2013-05-23 General Atomics Procedimientos para analizar el porcentaje de hemoglobina glicada
US7943385B2 (en) 2006-07-25 2011-05-17 General Atomics Methods for assaying percentage of glycated hemoglobin
WO2008063378A2 (en) 2006-11-01 2008-05-29 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
US8148105B2 (en) * 2007-03-16 2012-04-03 The Board Of Trustees Of The Leland Stanford Junior University Scaleable manufacturing process for cysteine endoprotease B, isoform 2
US7682789B2 (en) * 2007-05-04 2010-03-23 Ventana Medical Systems, Inc. Method for quantifying biomolecules conjugated to a nanoparticle
JP2010528285A (ja) 2007-05-23 2010-08-19 ベンタナ・メデイカル・システムズ・インコーポレーテツド 免疫組織化学およびinsituハイブリダーゼーションのためのポリマー担体
EP2283149A1 (en) * 2008-05-13 2011-02-16 General Atomics Electrochemical biosensor for direct determination of percentage of glycated hemoglobin
WO2009149013A2 (en) 2008-06-05 2009-12-10 Ventana Medical Systems, Inc. Compositions comprising nanomaterials and method for using such compositions for histochemical processes
USPP22463P3 (en) * 2010-02-16 2012-01-17 Menachem Bornstein Gypsophila plant named ‘Pearl Blossom’
EP2423217A1 (en) 2010-08-23 2012-02-29 Forschungsverbund Berlin E.V. Peptide and protein affinity tag from mistic protein
CN112592931A (zh) * 2020-12-31 2021-04-02 安徽丰原发酵技术工程研究有限公司 一种生产重组蛋白酶k的方法
CN118165964B (zh) * 2024-04-11 2025-01-24 铭诚惠众(江苏)药物研究有限公司 一种重组蛋白酶k的纯化方法及其应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332805A (en) * 1984-02-03 1994-07-26 Celltech Limited Process for the recovery of recombinantly produced chymosin from insoluble aggregate
US5082775A (en) * 1984-05-11 1992-01-21 Berlex Laboratories, Inc. Efficient process for isolating insoluble heterologous protein using non-ionic detergents
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US5453363A (en) * 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
AU617996B2 (en) * 1987-04-03 1991-12-12 Amgen, Inc. Novel proteolytic enzymes
DE3835350A1 (de) * 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
US5191063A (en) * 1989-05-02 1993-03-02 University Of Medicine And Dentistry Of New Jersey Production of biologically active polypeptides by treatment with an exogenous peptide sequence
US5606031A (en) * 1990-04-06 1997-02-25 Lile; Jack Production and purification of biologically active recombinant neurotrophic protein in bacteria
US5144006A (en) * 1991-06-13 1992-09-01 The Rockefeller University Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides
US5792623A (en) * 1992-04-06 1998-08-11 Immuno Aktiengesellschaft Method for producing activated blood factors with a protease and a detergent
DE4225427A1 (de) * 1992-07-31 1994-02-03 Boehringer Mannheim Gmbh Verfahren zur Gewinnung rekombinanter, biologisch aktiver, eukaryontischer alkalischer Phosphatase
CA2155335C (en) * 1993-02-04 2001-06-05 HANS CHRISTIAN THõGERSEN Improved method for the refolding of proteins
US5747654A (en) * 1993-06-14 1998-05-05 The United States Of America As Represented By The Department Of Health And Human Services Recombinant disulfide-stabilized polypeptide fragments having binding specificity
JPH0748398A (ja) * 1993-08-03 1995-02-21 Nippon Oil Co Ltd 変性蛋白質の再生方法及び変性蛋白質再生剤
US5550262A (en) * 1994-11-14 1996-08-27 Cephalon, Inc. Multicatalytic protease inhibitors
IL117350A0 (en) * 1995-03-09 1996-07-23 Procter & Gamble Proteinase k variants having decreased adsorption and increased hydrolysis
US6342585B1 (en) * 1996-06-11 2002-01-29 Roche Diagnostics Gmbh Method of activating denatured protein
US6426075B1 (en) * 1996-11-06 2002-07-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protease-activatable pseudomonas exotoxin A-like proproteins
US20030207402A1 (en) * 1997-08-22 2003-11-06 Erhard Kopetzki Autocatalytically activatable zymogenic precursors of proteases and their use
WO2000034504A2 (en) * 1998-12-10 2000-06-15 Genetic Vectors, Inc. Method of protein removal
US7351549B2 (en) * 2000-01-24 2008-04-01 Polymun Scientific Immunbiologische Forschung Gmbh Method for the manufacture of recombinant trypsin
US7001724B1 (en) * 2000-11-28 2006-02-21 Applera Corporation Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
MXPA03004835A (es) * 2000-12-15 2005-04-19 Boehringer Ingelheim Ltd Proteasa ns2/3 activa, purificada de virus de hepatitis c.
US7214484B2 (en) * 2002-12-17 2007-05-08 Sigma-Aldrich Co. Compositions and methods for nucleic acid extraction from biological samples

Also Published As

Publication number Publication date
EP1360284B1 (de) 2008-07-16
CA2435753A1 (en) 2002-09-19
DE50212510D1 (de) 2008-08-28
US20070099283A1 (en) 2007-05-03
WO2002072634A2 (de) 2002-09-19
CZ20032165A3 (cs) 2004-10-13
EP1360284A2 (de) 2003-11-12
JP2004525631A (ja) 2004-08-26
WO2002072634A3 (de) 2003-03-13
ATE401393T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
KR101837802B1 (ko) 신규 prongf 돌연변이체 및 베타-ngf의 제조에서의 이의 용도
DE60034707T2 (de) Allgemeines verfahren zur rückfaltung rekombinanter proteine
EP1360284B1 (de) Rekombinante proteinase k
EP1360283B1 (de) Expression der rekombinanten proteinase k aus tritirachium album in hefe
CA2605140A1 (en) Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
KR20010083900A (ko) 활성 β-NGF의 제조방법
EP0242836A1 (de) Gewebs-Plasminogen-Aktivator (tPA) - Derivat und seine Herstellung
McCaman et al. Enzymatic properties and processing of bovine prochymosin synthesized in Escherichia coli
DE10059336A1 (de) Herstellung von rekombinantem BMP-2
Kelley et al. Renaturation of cobra venom phospholipase A2 expressed from a synthetic gene in Escherichia coli
EP1012307B1 (de) Autokatalytisch aktivierbare zymogene vorstufen von proteasen und deren verwendung
DE4020438A1 (de) Plasmide, deren herstellung und deren verwendung bei der gewinnung eines plasminogenaktivators
DE19943177A1 (de) Verfahren zur Herstellung von aktiven Serienproteasen und inaktiven Varianten
EP2561071B1 (de) Verfahren zur herstellung von rekombinantem thrombin
EP1169461B1 (de) Verwendung von pankreatischer Procarboxypeptidase B zur Herstellung von Insulin
RU2143492C1 (ru) Рекомбинантная плазмида, кодирующая гибридный белок - предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка - предшественника инсулина человека (варианты), способ получения инсулина человека
KR100251285B1 (ko) 재조합 인간성장호르몬의 정제방법
DE102004013955B4 (de) Verfahren zur Herstellung von rekombinanter RNase A
WO1999010483A2 (de) Autokatalytisch aktivierbare vorstufen von proteasen und deren verwendung
Yonezawa et al. Role of the amino-terminal amino acid sequences determining the in vitro refolding process of prochymosin polypeptide
EP3440203B1 (de) Neue protease mit verbesserter waschleistung
HK40004284A (en) Novel prongf mutants and uses thereof in the production of beta-ngf
DE10148723A1 (de) Mutierte Glutarylamidase und deren Verwendung zur Herstellung von 7-Amino-Cephalosporansäure (7-ACS) und deren Derivaten
DD220335A5 (de) Herstellung funktioneller menschlicher urokinase-proteine
EP1623232A2 (de) Anreicherung von enzymatischen spaltprodukten

Legal Events

Date Code Title Description
8141 Disposal/no request for examination